Use of imidazoquinolines for the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members

Details for Australian Patent Application No. 2011265510 (hide)

Owner Novartis AG

Inventors Garcia-Echeverria, Carlos; Maira, Sauveur-Michel

Agent Davies Collison Cave

Pub. Number AU-A-2011265510

Parent 2008280105

Filing date 22 December 2011

Wipo publication date 2 February 2012

International Classifications

A61K 31/444 (2006.01)

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 January 2012 Complete Application Filed

2 February 2012 Application Open to Public Inspection

  Published as AU-A-2011265510

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011265511-Locking turret

2011265509-RNA constructs